(Q35443960)

8 August 2017

title

Tumour characteristics and prognosis of breast cancer patients carrying the germline CHEK2*1100delC variant (English)

1 reference

8 August 2017

1 reference

10

Devilee P

1 reference

8 August 2017

4

Seynaeve C

1 reference

8 August 2017

Christi J van Asperen

8

object named as

van Asperen CJ

1 reference

8 August 2017

Hanne Meijers-Heijboer

7

object named as

Meijers-Heijboer H

1 reference

8 August 2017

de Bock GH

1

1 reference

8 August 2017

Schutte M

2

1 reference

8 August 2017

Krol-Warmerdam EM

3

1 reference

8 August 2017

Blom J

5

1 reference

8 August 2017

Brekelmans CT

6

1 reference

8 August 2017

Cornelisse CJ

9

1 reference

8 August 2017

Tollenaar RA

11

1 reference

8 August 2017

Klijn JG

12

1 reference

8 August 2017

language of work or name

English

0 references

publication date

1 October 2004

1 reference

Journal of Medical Genetics

8 August 2017

published in

1 reference

8 August 2017

volume

41

1 reference

8 August 2017

issue

10

1 reference

8 August 2017

page(s)

731-735

1 reference

The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype

8 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1735606

A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1735606

Clinical and pathological features of BRCA1 associated carcinomas in a hospital-based sample of Dutch breast cancer patients

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1735606

After BRCA1 and BRCA2-what next? Multifactorial segregation analyses of three-generation, population-based Australian families affected by female breast cancer

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1735606

Are BRCA1- and BRCA2-associated breast cancers different? Prognosis of BRCA1-associated breast cancer.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1735606

The influence of familial and hereditary factors on the prognosis of breast cancer.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1735606

Breast carcinomas arising in carriers of mutations in BRCA1 or BRCA2: are they prognostically different?

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1735606

Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1735606

Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1735606

DNA-dependent protein kinase and checkpoint kinase 2 synergistically activate a latent population of p53 upon DNA damage

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1735606

Are BRCA1- and BRCA2-related breast cancers associated with increased mortality?

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1735606

Chk1 and Chk2 kinases in checkpoint control and cancer

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1735606

Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1735606

A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1735606

Prognostic significance of germline BRCA2 mutations in hereditary breast cancer patients

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1735606

Prognostic value of estrogen and progesterone receptors in operable breast cancer. Results of a univariate and multivariate analysis

26 September 2018

1 reference

12 December 2020

Polygenic susceptibility to breast cancer and implications for prevention

1 reference

12 December 2020

Effect of germ-line genetic variation on breast cancer survival in a population-based study

1 reference

12 December 2020

The CHEK2*1100delC variant acts as a breast cancer risk modifier in non-BRCA1/BRCA2 multiple-case families

1 reference

12 December 2020

Identifiers

DOI

10.1136/JMG.2004.019737

1 reference

8 August 2017

1 reference

8 August 2017

1 reference